Literature DB >> 6430559

Randomized trial of hexamethylmelamine versus 5-FU, doxorubicin, and cyclophosphamide (FAC) in advanced transitional cell bladder carcinoma: a Southwest Oncology Group study.

R G Gagliano, R L Stephens, J J Costanzi, N Oishi, W J Stuckey, P N Grozea, J Frank, E D Crawford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6430559

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

Review 1.  Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy.

Authors:  C R Lee; D Faulds
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

Review 2.  Chemotherapy of advanced transitional-cell carcinoma of the bladder.

Authors:  R S Miller; F M Torti
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  In vitro and in vivo responses of a murine transitional cell carcinoma to doxorubicin, mitoxantrone and aclacinomycin-A.

Authors:  R J Ballou; M T Tseng
Journal:  Urol Res       Date:  1986
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.